PHIN Stock Analysis: PHINIA | NYSE
Auto Parts | NYSE, USA | Market Cap: 2.072m USD | 12M Return: 7.6% | US71880K1016 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 25.7M
Qual. Beats: 0
Rev. Trend: 16.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 3.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
PHINIA Inc. is a U.S.-based automotive components manufacturer that develops, designs, and produces integrated components and systems through two reporting segments. The Fuel Systems segment supplies advanced fuel injection systems, including pumps, injectors, fuel rail assemblies, engine control modules, fuel delivery modules, canisters, sensors, and electronic control modules, along with complete calibrated systems and software for traditional and hybrid applications. The Aftermarket segment offers maintenance and test equipment, vehicle diagnostics, original equipment service solutions, remanufactured products, and starters and alternators sold to OEMs. Its products serve commercial vehicles, industrial applications (medium- and heavy-duty trucks, buses, off-highway construction, marine, agricultural, aerospace and defense), light commercial vehicles, and light passenger vehicles. PHINIA was incorporated in 2023 and is headquartered in Auburn Hills, Michigan.
The automotive parts and equipment industry is structured around long-term supply relationships with vehicle manufacturers, where suppliers typically engineer components to specific platform requirements. Tier 1 suppliers commonly operate a dual-channel model, generating revenue from OEM assembly contracts while also capturing aftermarket demand for replacement parts, diagnostics, and remanufactured components tied to vehicles already in service.
- Tightening emissions standards lift fuel injection system demand
- Aftermarket remanufactured products drive stable recurring revenue
- Commercial vehicle cycle exposure pressures near-term segment volumes
| Net Income: 135.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.26 > 1.0 |
| NWC/Revenue: 22.68% < 20% (prev 25.82%; Δ -3.14% < -1%) |
| CFO/TA 0.09 > 3% & CFO 359.0m > Net Income 135.0m |
| Net Debt (735.0m) to EBITDA (441.0m): 1.67 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.0m) vs 12m ago -5.47% < -2% |
| Gross Margin: 21.83% > 18% (prev 21.56%; Δ 0.27% > 0.5%) |
| Asset Turnover: 93.46% > 50% (prev 86.24%; Δ 7.22% > 0%) |
| Interest Coverage Ratio: 3.40 > 6 (EBIT TTM 279.0m / Interest Expense TTM 82.0m) |
| A: 0.21 (Total Current Assets 1.84b - Total Current Liabilities 1.02b) / Total Assets 3.84b |
| B: 0.05 (Retained Earnings 187.0m / Total Assets 3.84b) |
| C: 0.07 (EBIT TTM 279.0m / Avg Total Assets 3.87b) |
| D: 0.67 (Book Value of Equity 1.54b / Total Liabilities 2.30b) |
| Altman-Z'' = 2.75 = A |
| DSRI: 0.88 (Receivables 853.0m/905.0m, Revenue 3.62b/3.36b) |
| GMI: 0.99 (GM 21.56% / 21.83%) |
| AQI: 1.07 (AQ_t 0.30 / AQ_t-1 0.28) |
| SGI: 1.08 (Revenue 3.62b / 3.36b) |
| TATA: -0.06 (NI 135.0m - CFO 359.0m) / TA 3.84b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of October 15, 2026, the stock is trading at USD 55.84 with a total of 651,690 shares traded. Over the past week, the price has changed by -4.50%, over one month by -11.10%, over three months by -28.32% and over the past year by +7.55%.
Current recommended Stop Loss: 53.60 (which is 4% or 1.3 ATR below the current price).
PHINIA has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy PHIN.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 91.6 | 64% |
P/E Trailing = 16.2006
P/E Forward = 9.9108
P/S = 0.573
P/B = 1.4358
Revenue TTM = 3.62b USD
EBIT TTM = 279.0m USD
EBITDA TTM = 441.0m USD
Long Term Debt = 968.0m USD (from longTermDebt, last quarter)
Short Term Debt = 70.0m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 43.0m
Net Debt = 735.0m USD (calculated: Debt 1.10b - CCE 370.0m)
Enterprise Value = 2.81b USD (2.07b + Debt 1.10b - CCE 370.0m)
Interest Coverage Ratio = 3.40 (Ebit TTM 279.0m / Interest Expense TTM 82.0m)
EV/FCF = 9.23x (Enterprise Value 2.81b / FCF TTM 304.0m)
FCF Yield = 10.83% (FCF TTM 304.0m / Enterprise Value 2.81b)
FCF Margin = 8.41% (FCF TTM 304.0m / Revenue TTM 3.62b)
Net Margin = 3.73% (Net Income TTM 135.0m / Revenue TTM 3.62b)
Gross Margin = 21.83% ((Revenue TTM 3.62b - Cost of Revenue TTM 2.83b) / Revenue TTM)
Gross Margin QoQ = 22.98% (prev 21.41%)
Tobins Q-Ratio = 0.73 (Enterprise Value 2.81b / Total Assets 3.84b)
Interest Expense / Debt = 7.42% (Interest Expense 82.0m / Debt 1.10b)
Taxrate = 31.47% (62.0m / 197.0m)
NOPAT = 191.2m (EBIT 279.0m * (1 - 31.47%))
Current Ratio = 1.81 (Total Current Assets 1.84b / Total Current Liabilities 1.02b)
Debt / Equity = 0.72 (Debt 1.10b / totalStockholderEquity, last quarter 1.54b)
Debt / EBITDA = 1.67 (Net Debt 735.0m / EBITDA 441.0m)
Debt / FCF = 2.42 (Net Debt 735.0m / FCF TTM 304.0m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.49% (Net Income 135.0m / Total Assets 3.84b)
RoE = 8.62% (Net Income TTM 135.0m / Total Stockholder Equity 1.57b)
RoCE = 11.01% (EBIT 279.0m / Capital Employed (Equity 1.57b + L.T.Debt 968.0m))
RoIC = 7.05% (NOPAT 191.2m / Invested Capital 2.71b)
WACC = 7.66% (E(2.07b)/V(3.18b) * Re(9.03%) + D(1.10b)/V(3.18b) * Rd(7.42%) * (1-Tc(0.31)))
Discount Rate = 9.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.12 | Cagr: -8.58%
[DCF] Terminal Value 77.97% ; FCFF base≈270.4m ; Y1≈310.0m ; Y5≈456.2m
[DCF] Fair Price = 167.3 (EV 6.86b - Net Debt 735.0m = Equity 6.13b / Shares 36.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.21 | # QB: 0
Revenue Correlation: 16.53 | Revenue CAGR: 0.43% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.68 | Chg30d=-0.53% | Revisions=-38% | Analysts=5
EPS current Year (2026-12-31): EPS=5.94 | Chg30d=-0.47% | Revisions=-62% | GrowthEPS=+19.7% | GrowthRev=+4.6%
EPS next Year (2027-12-31): EPS=6.85 | Chg30d=-0.79% | Revisions=+38% | GrowthEPS=+15.3% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: -28% (up=5, down=10)